The North America Cell Separation Market should witness market growth of 9.5% CAGR during the forecast period (2023-2030).
The rise in chronic diseases is predicted to accelerate the adoption of cell separation technologies such as the development of regenerative medicines or tissue engineering. The market is expected to expand throughout the forecasted period due to technological advancements in cell separation technologies and increased government initiatives to support the cell separation procedure.
Over 1.9 million new cases of cancer are anticipated to be diagnosed in the United States alone in 2023, according to the American Cancer Society. Around 1.5 million new cases of hepatitis C are reported each year, and the WHO estimates that 58 million individuals regionally have chronic hepatitis C infection. Instruments and related products are indispensable in disease diagnosis and scientific research, as they can produce accurate and reliable results.
Government initiatives and legislation about biomedical research activities are escalating quickly due to increased public awareness of the aging population and the rising frequency of chronic diseases. The market expanded quickly as a result of this. Market’s growth is predicted to be accelerated by investments in the biotechnology industry and improvements to the healthcare infrastructure.
Cancer has a significant impact on the United States. The number of new cancer cases expected to be diagnosed in the US in 2020 was 1,806,590, while the number of cancer-related deaths is predicted to be 606,520. There were reportedly 16.9 million cancer survivors in the United States as of January 2019. Up to 2030, there are expected to be 22.2 million cancer survivors. There were 2,122 HIV diagnoses reported in Canada overall 2019 (5.6 per 100,000 people). At 16.9 per 100,000 population, Saskatchewan had the greatest provincial diagnosis rate. At 12.7 per 100,000 people, the age group of 30 to 39 had the highest prevalence of HIV diagnosis. As a result of the rising HIV/AIDS and cancer patients across the regional nations, the market is estimated to grow at a steady rate.
The US market dominated the North America Cell Separation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,780.7 million by 2030. The Canada market is experiencing a CAGR of 12% during (2023-2030). Additionally, The Mexico market would exhibit a CAGR of 11% during (2023-2030).
Based on Product Type, the market is segmented into Consumables (Reagents, Kits, Media, & Sera, Disposables, and Beads), and Instruments (Centrifuges, Flow Cytometers, Filtration Systems, and Magnetic-activated Cell Separator Systems). Based on End-Use, the market is segmented into Biotechnology & Biopharmaceutical Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Laboratories, and Cell Banks. Based on Cells Type, the market is segmented into Animal Cell, and Human Cell. Based on Technique, the market is segmented into Centrifugation, Surface Marker, and Filtration. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, and Therapeutics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Corning Incorporated, Terumo Corporation, STEMCELL Technologies, Inc. and Akadeum Life Sciences, Inc.
The rise in chronic diseases is predicted to accelerate the adoption of cell separation technologies such as the development of regenerative medicines or tissue engineering. The market is expected to expand throughout the forecasted period due to technological advancements in cell separation technologies and increased government initiatives to support the cell separation procedure.
Over 1.9 million new cases of cancer are anticipated to be diagnosed in the United States alone in 2023, according to the American Cancer Society. Around 1.5 million new cases of hepatitis C are reported each year, and the WHO estimates that 58 million individuals regionally have chronic hepatitis C infection. Instruments and related products are indispensable in disease diagnosis and scientific research, as they can produce accurate and reliable results.
Government initiatives and legislation about biomedical research activities are escalating quickly due to increased public awareness of the aging population and the rising frequency of chronic diseases. The market expanded quickly as a result of this. Market’s growth is predicted to be accelerated by investments in the biotechnology industry and improvements to the healthcare infrastructure.
Cancer has a significant impact on the United States. The number of new cancer cases expected to be diagnosed in the US in 2020 was 1,806,590, while the number of cancer-related deaths is predicted to be 606,520. There were reportedly 16.9 million cancer survivors in the United States as of January 2019. Up to 2030, there are expected to be 22.2 million cancer survivors. There were 2,122 HIV diagnoses reported in Canada overall 2019 (5.6 per 100,000 people). At 16.9 per 100,000 population, Saskatchewan had the greatest provincial diagnosis rate. At 12.7 per 100,000 people, the age group of 30 to 39 had the highest prevalence of HIV diagnosis. As a result of the rising HIV/AIDS and cancer patients across the regional nations, the market is estimated to grow at a steady rate.
The US market dominated the North America Cell Separation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,780.7 million by 2030. The Canada market is experiencing a CAGR of 12% during (2023-2030). Additionally, The Mexico market would exhibit a CAGR of 11% during (2023-2030).
Based on Product Type, the market is segmented into Consumables (Reagents, Kits, Media, & Sera, Disposables, and Beads), and Instruments (Centrifuges, Flow Cytometers, Filtration Systems, and Magnetic-activated Cell Separator Systems). Based on End-Use, the market is segmented into Biotechnology & Biopharmaceutical Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Laboratories, and Cell Banks. Based on Cells Type, the market is segmented into Animal Cell, and Human Cell. Based on Technique, the market is segmented into Centrifugation, Surface Marker, and Filtration. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, and Therapeutics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Corning Incorporated, Terumo Corporation, STEMCELL Technologies, Inc. and Akadeum Life Sciences, Inc.
Scope of the Study
By Product Type
- Consumables
- Reagents, Kits, Media, & Sera
- Disposables
- Beads
- Instruments
- Centrifuges
- Flow Cytometers
- Filtration Systems
- Magnetic-activated Cell Separator Systems
By End-Use
- Biotechnology & Biopharmaceutical Companies
- Research Laboratories & Institutes
- Hospitals & Diagnostic Laboratories
- Cell Banks
By Cells Type
- Animal Cell
- Human Cell
By Technique
- Centrifugation
- Surface Marker
- Filtration
By Application
- Biomolecule Isolation
- Cancer Research
- Stem Cell Research
- Tissue Regeneration
- In Vitro Diagnostics
- Therapeutics
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- Terumo Corporation
- STEMCELL Technologies, Inc.
- Akadeum Life Sciences, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Cell Separation Market by Product Type
Chapter 6. North America Cell Separation Market by End-Use
Chapter 7. North America Cell Separation Market by Cells Type
Chapter 8. North America Cell Separation Market by Technique
Chapter 9. North America Cell Separation Market by Application
Chapter 10. North America Cell Separation Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- Terumo Corporation
- STEMCELL Technologies, Inc.
- Akadeum Life Sciences, Inc.
Methodology
LOADING...
